Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synergistic clindamycin + camel milk exosome + aloe vera cream vs clindamycin for cetuximab-induced acneiform rash
IRCT20250427065485N1Phase 2Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clindamycin and aloe vera in acneiform rash and drug hypersensitivity syndrome (DRESS) (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
clindamycinaloe vera
03
Conditions
acneiform rashdrug hypersensitivity syndrome (DRESS)
Beyond the preview
Go deeper on IRCT20250427065485N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250427065485N1.